ArticleDiagnostic and interventional radiology (Ankara, Turkey)2025
Breast cancer detection and classification with digital breast tomosynthesis: a two-stage deep learning approach.
Article in Diagnostic and interventional radiology (Ankara, Turkey), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A Systematic Literature Review of You Only Look Once Architectures (v1-v12) in Healthcare Systems.Diagnostics (Basel, Switzerland) · 2026Review
- Multimodal deep learning for breast tumor classification: Integrating mammography and ultrasound for enhanced diagnostic accuracy.Journal of applied clinical medical physics · 2026Article
- Breast Cancer Classification with Various Optimized Deep Learning Methods.Diagnostics (Basel, Switzerland) · 2025Article
- Bridging the Gap Between Accuracy and Efficiency in AI-Based Breast Cancer Diagnosis from Histopathological Data.Cancers · 2025Article
- Deep Learning with Transfer Learning on Digital Breast Tomosynthesis: A Radiomics-Based Model for Predicting Breast Cancer Risk.Diagnostics (Basel, Switzerland) · 2025Article
- Combining shallow and deep neural networks on pseudo-color enhanced images for digital breast tomosynthesis lesion classification.Frontiers in digital health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose of this study was to propose a new computer-assisted two-staged diagnosis system that combines a modified deep learning (DL) architecture (VGG19) for the classification of digital breast tomosynthesis (DBT) images with the detection of tumors as benign or cancerous using the You Only Look Once version 5 (YOLOv5) model combined with the convolutional block attention module (CBAM) (known as YOLOv5-CBAM).
methodsIn the modified version of VGG19, eight additional layers were integrated, comprising four batch normalization layers and four additional pooling layers (two max pooling and two average pooling). The CBAM was incorporated into the YOLOv5 model structure after each feature fusion. The experiment was carried out using a sizable benchmark dataset of breast tomography images. A total of 22,032 DBT examinations from 5,060 patients were included in the data.
resultsTest accuracy, training loss, and training accuracy showed better performance with our proposed architecture than with previous models. Hence, the modified VGG19 classified DBT images more accurately than previously possible using pre-trained model-based architectures. Furthermore, a YOLOv5-based CBAM precisely discriminated between benign lesions and those that were malignant.
conclusionDBT images can be classified using modified VGG19 with accuracy greater than the previously available pre-trained models-based architectures. Furthermore, a YOLOv5-based CBAM can precisely distinguish between benign and cancerous lesions. CLINICAL SIGNIFICANCE: The proposed two-tier DL algorithm, combining a modified VGG19 model for image classification and YOLOv5-CBAM for lesion detection, can improve the accuracy, efficiency, and reliability of breast cancer screening and diagnosis through innovative artificial intelligence-driven methodologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.